SEC Form D · filed February 5, 2024
RedHill Biopharma Ltd
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (36)
Razi Ingber · Tel Aviv, L3ExecEric Swenden · Tel Aviv, L3DirectorAlla D. Felder · Tel Aviv, L3DirectorAdi D. Frish · Tel Aviv, L3ExecRick D. Scruggs · Tel Aviv, L3Exec · DirectorReza D. Fathi · Tel Aviv, L3ExecShmuel Cabilly · Tel Aviv, L3DirectorDror Ben-Asher · Tel Aviv, L3Exec · DirectorOfer Tsimchi · Tel Aviv, L3DirectorGuy D. Goldberg · Tel Aviv, L3ExecGilead D. Raday · Tel Aviv, L3ExecKenneth Reed · Tel Aviv, L3DirectorIngrid Mulder · Amstelveen, P7Exec · DirectorJoshua E. Wyss · Mill Valley, CADirectorCleon N. Daskalakis · Boston, MAExecKen Johnson · Franklin, MIDirectorBruce W. Snyder · Seattle, WAExec · DirectorPeter R. Kagan · Tulsa, OKExecAldo Zini · Turtle Creek, PADirectorRazi Ingber · Tel Aviv, L3ExecJeffrey N. Vale · Atlanta, GAExecBrandon Contino · Turtle Creek, PAExecMohamed Arafa · Amstelveen, P7DirectorGaurav Gambhir · Philadelphia, PADirectorJosh S. Stein · Palo Alto, CADirectorSteven A. Anderson · SOUTH PASADENA, CADirectorJohn C. Power · VACAVILLE, CAExec · DirectorBrian C. Power · VACAVILLE, CADirectorJacob S. Horne · SAN FRANCISCO, CAExecDavid Meredith · NEWPORT BEACH, CAExecRick Taketa · CORONA DEL MAR, CAExecDarren O'Brien · WAN CHAI, Hong KongDirectorSimone Blank · NEWPORT BEACH, CAExec · DirectorJost Fischer · NEWPORT BEACH, CADirectorDouglas Buchalter · Asheville, NCExecSusan C. Schnabel · New York, NYExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗